Global Gene Sequencing Supply, Demand and Key Producers, 2026-2032

The global Gene Sequencing market size is expected to reach $ 88660 million by 2032, rising at a market growth of 17.5% CAGR during the forecast period (2026-2032).

Gene sequencing is a laboratory process used to determine the exact sequence of nucleotides (the building blocks of DNA) within a gene or genome. This technique allows scientists to decode the genetic information contained in an organism’s DNA, providing insights into its genetic makeup and how it relates to health, disease, and inheritance. Modern methods, such as next-generation sequencing (NGS), enable rapid and high-throughput sequencing, making it possible to analyze entire genomes quickly and at lower costs than traditional methods. Gene sequencing plays a crucial role in areas like personalized medicine, genetic counseling, and disease diagnosis.

The gene sequencing market is largely driven by the rapid advancements in genomics technologies, which have significantly reduced the cost and time required for sequencing. With innovations such as next-generation sequencing (NGS), the ability to sequence an individual's entire genome has become more accessible, fueling growth in personalized medicine, genetic testing, and diagnostics. The increasing prevalence of genetic disorders, cancer, and rare diseases has further expanded the demand for genetic testing and analysis, allowing for more precise treatment plans and early detection of conditions. Additionally, the integration of artificial intelligence and bioinformatics tools with gene sequencing is enhancing data analysis and interpretation, boosting the market.

However, the gene sequencing market faces challenges such as ethical concerns, data privacy issues, and regulatory complexities. The handling and interpretation of vast amounts of genetic data raise concerns about confidentiality and the potential misuse of information, particularly in areas like genetic discrimination. Furthermore, the high initial costs of sequencing technologies and the need for specialized expertise in bioinformatics to analyze complex data can limit access for smaller healthcare institutions or emerging markets. Despite these challenges, the increasing demand for advanced genetic testing and precision medicine continues to drive the growth of the gene sequencing market.

Global core gene sequencing companies include Illumina, Thermo Fisher Scientific and Eurofins Scientific etc. The top 3 companies hold a share about 31%. North America is the largest market, with a share about 33%, followed by Europe and Asia Pacific with the share about 32% and 21%. In terms of product, next-generation sequencing is the largest segment with a share about 82%. And in terms of application, the largest application is academic research with a share about 53%.

This report studies the global Gene Sequencing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Gene Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Sequencing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Gene Sequencing total market, 2021-2032, (USD Million)

Global Gene Sequencing total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Gene Sequencing total market, key domestic companies, and share, (USD Million)

Global Gene Sequencing revenue by player, revenue and market share 2021-2026, (USD Million)

Global Gene Sequencing total market by Type, CAGR, 2021-2032, (USD Million)

Global Gene Sequencing total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Gene Sequencing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Genomics, Natera, Berry Genomics, Roche, Novogene, Mgi Tech, LabCorp, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Sequencing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Gene Sequencing Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Gene Sequencing Market, Segmentation by Type:
Next-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing

Global Gene Sequencing Market, Segmentation by Application:
Academic Research
Clinical Research
Hospital Clinic
Pharmaceuticals and Biotechnology
Others

Companies Profiled:
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI Genomics
Natera
Berry Genomics
Roche
Novogene
Mgi Tech
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen

Key Questions Answered

1. How big is the global Gene Sequencing market?

2. What is the demand of the global Gene Sequencing market?

3. What is the year over year growth of the global Gene Sequencing market?

4. What is the total value of the global Gene Sequencing market?

5. Who are the Major Players in the global Gene Sequencing market?

6. What are the growth factors driving the market demand? Show more